Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma. Yang L, Pham K, Xi Y, Wu Q, et al. PLoS One 2025;20:e0317401.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang L, Pham K, Xi Y, Wu Q, et al. Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma. PLoS One 2025;20:e0317401.
PMID: 39841705